CHRW
56
2
NVDA
60
-3
JBHT
28
-14
FLS
75
8
CTSH
49
-2
ORCL
68
3
FOX
50
2
HES
68
2
IFF
69
13
WDC
49
-4
TJX
58
-3
ABT
45
-3
GOOG
75
2
HUM
43
-4
BEN
41
-9
BMY
35
2
PVH
67
-2
GT
49
-3
HST
39
-5
C
48
-2
CHRW
56
2
NVDA
60
-3
JBHT
28
-14
FLS
75
8
CTSH
49
-2
ORCL
68
3
FOX
50
2
HES
68
2
IFF
69
13
WDC
49
-4
TJX
58
-3
ABT
45
-3
GOOG
75
2
HUM
43
-4
BEN
41
-9
BMY
35
2
PVH
67
-2
GT
49
-3
HST
39
-5
C
48
-2
Financhill
Back

InMed Pharmaceuticals 10K Form

Sell
37

INM
InMed Pharmaceuticals

Last Price:
0.30
Seasonality Move:
-26.37%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive INM News And Ratings

See the #1 stock for the next 7 days that we like better than INM

INM Financial Statistics

Sales & Book Value

Annual Sales: $4.14M
Cash Flow: $-1.93M
Price / Cash Flow: 0
Annual Sales: $1.83
Price / Book: 0.16

Profitability

EPS (TTM): -0.85000
Net Income (TTM): $-6.08M
Gross Margin: $1.4M
Return on Equity: -52.44%
Return on Assets: -44.44%

InMed Pharmaceuticals Earnings Forecast

Key InMed Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 23 years for INM is 33.93%.
  • The Selling, General & Administrative Expenses for INM have been equal to 141.40% of Gross Profit Margin.
  • The Research & Development expenses have been 90.24% of Revenue.
  • The Interest Expense is -3.53% of Operating Income.
  • Per Share Earnings over the last 23 years have been positive in 14 years.

InMed Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: INM
Website: inmedpharma.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 6.58
Quick Ratio: 5.11

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

INM Technical Analysis vs Fundamental Analysis

Sell
37
InMed Pharmaceuticals (INM) is a Sell

Is InMed Pharmaceuticals a Buy or a Sell?